Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Philippines Orders Recall Of Novartis Prexige Because Of Liver Damage

This article was originally published in PharmAsia News

Executive Summary

Philippine authorities ordered the Novartis anti-inflammatory painkiller Prexige (lumiracoxib) recalled because of an increased risk of liver damage. The Cox-2 selective inhibitor for treating osteoarthritis and dysmenorrhia has been withdrawn recently in several other countries. The Philippines Bureau of Food and Drugs said it had determined the drug could cause liver damage. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts